RxSight Inc (RXST)
44.83
-0.22
(-0.49%)
USD |
NASDAQ |
Nov 22, 16:00
44.85
+0.02
(+0.04%)
After-Hours: 20:00
RxSight Cash from Investing (Quarterly): -9.26M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -9.26M |
| June 30, 2024 | -115.64M |
| March 31, 2024 | 24.27M |
| December 31, 2023 | 4.566M |
| September 30, 2023 | 17.28M |
| June 30, 2023 | 4.395M |
| March 31, 2023 | -48.36M |
| December 31, 2022 | 10.40M |
| September 30, 2022 | 0.56M |
| June 30, 2022 | 14.13M |
| Date | Value |
|---|---|
| March 31, 2022 | 14.86M |
| December 31, 2021 | -35.35M |
| September 30, 2021 | -80.24M |
| June 30, 2021 | 19.18M |
| March 31, 2021 | 14.50M |
| December 31, 2020 | -14.52M |
| September 30, 2020 | 6.405M |
| June 30, 2020 | -0.523M |
| March 31, 2020 | 24.22M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-115.64M
Minimum
Jun 2024
24.27M
Maximum
Mar 2024
-7.849M
Average
4.566M
Median
Dec 2023
Cash from Investing (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | -19.90M |
| PROCEPT BioRobotics Corp | -0.246M |
| Perspective Therapeutics Inc | -29.74M |
| Xtant Medical Holdings Inc | -2.009M |
| Catheter Precision Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.65M |
| Cash from Financing (Quarterly) | 0.878M |
| Free Cash Flow | -27.17M |
| Free Cash Flow Per Share (Quarterly) | -0.0114 |
| Free Cash Flow to Equity (Quarterly) | -0.453M |
| Free Cash Flow to Firm (Quarterly) | -0.453M |
| Free Cash Flow Yield | -1.60% |